SCHEMBL10741095

SCHEMBL10741095

C#CCOc1cc(O)ccc1-c1nc2cnncc2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AMY1A P0DUB6 2/20 0.38
▸ CDK4 P11802 3/20 0.35
▸ CCNA2 P20248 3/20 0.35
▸ CCND1 P24385 3/20 0.35
▸ CDK2 P24941 3/20 0.35
▸ CCND3 P30281 3/20 0.35
▸ GUSB P08236 1/20 0.34
▸ PDE5A O76074 4/20 0.34
▸ PDE3B Q13370 1/20 0.34
▸ PDE3A Q14432 1/20 0.34
▸ TOP1 P11387 1/20 0.34
▸ TOP2A P11388 1/20 0.34
▸ MAOB P27338 2/20 0.34
▸ CBFB Q13951 1/20 0.33
▸ CHEK1 O14757 3/20 0.33
▸ KDR P35968 2/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ JAK1 P23458 1/20 0.33
▸ TYK2 P29597 1/20 0.33
▸ JAK3 P52333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10734673 0.88 AMY1A (0.38) AMY1ACDK4CCNA2CCND1CDK2
SCHEMBL10739175 0.87 TOP1 (0.41) PDE5APDE3BPDE3ATOP1TOP2A
SCHEMBL9634554 0.86 CDK4 (0.40) AMY1ACDK4CCNA2CCND1CDK2
SCHEMBL10735063 0.85 CYP1A1 (0.39) AMY1ATOP1TOP2AMAOBMGAM
SCHEMBL10739019 0.84 PDE2A (0.46) AMY1APDE5APDE3BPDE3ATOP1
SCHEMBL10739751 0.83 PDE5A (0.35) AMY1APDE5APDE3BPDE3ATOP1
SCHEMBL10740722 0.83 SMN1; SMN2 (0.42) PDE5APDE3BPDE3ATOP1TOP2A
SCHEMBL10736882 0.83 MAOB (0.48) GUSBPDE5AMAOBCYP1A1CYP1A2
SCHEMBL10735482 0.82 TOP1 (0.38) PDE5APDE3BPDE3ATOP1TOP2A
SCHEMBL10739803 0.82 TOP1 (0.38) PDE5APDE3BPDE3ATOP1TOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 — — US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 — — EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 — — US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 — — US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 — — EP disclosed
Send feedback